Redox bioscience
Thioredoxin-based drug discovery and functional foods.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Late VC | ||
| Total Funding | 000k | ||
Redox Bioscience Inc. is a venture company that originated from Kyoto University, established on November 1, 2001. The firm was founded based on the discoveries of Professor Junji Yodoi concerning the anti-stress protein thioredoxin (TRX). The company's President is Kiyoaki Yamauchi.
The company's business model is centered on translating basic research on thioredoxin and other anti-stress proteins into commercial products for the medical, food, and wellness sectors. It operates through a collaborative framework involving industry, academia, and government, working closely with the Kyoto University Institute for Virus Research, the Translational Research Center at Kyoto University Hospital, and the National Institute of Advanced Industrial Science and Technology (AIST). This collaboration allows Redox Bioscience to bridge the gap between foundational research and market-ready applications.
Redox Bioscience's activities are diversified across several areas. A primary focus is the development of pharmaceuticals for preventing and treating stress-related disorders. The company also develops functional foods, skincare, and cosmetics that utilize thioredoxin's properties to prevent allergies, protect mucous membranes, and provide antioxidant effects. Another significant business line is the creation of technologies and diagnostic kits, such as the Thioredoxin ELISA kit, for measuring stress levels by analyzing thioredoxin concentrations in blood and urine.
The firm engages in contract research and development in biotechnology and the manufacturing and sales of clinical diagnostic agents and research reagents. Its product portfolio includes items like the Anti-Mouse Thioredoxin-1 Antibody and Recombinant Human Thioredoxin.
Keywords: thioredoxin, TRX, drug discovery, biotechnology, stress measurement, functional foods, diagnostics, research reagents, Kyoto University venture, anti-stress protein, redox signaling, clinical diagnostics, skincare, cosmetics, pharmaceuticals, contract research, allergy prevention, antioxidant, academic collaboration, biopharmaceutical